바이오뱅크 시장 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of biobanking Market

The global biobanking market size was valued at USD 83.29 billion in 2025 and is projected to reach USD 91.05 billion in 2026, further expanding to USD 185.59 billion by 2034. The market is expected to exhibit a CAGR of 9.31% from 2026 to 2034. Europe dominated the global biobanking market with a 35.59% market share in 2025, supported by established biobank infrastructure, strong research capabilities, and continuous investments in biomedical research.

Biobanking involves the collection, processing, preservation, storage, and distribution of biological samples such as blood, plasma, serum, urine, tissues, and cells. Increasing investments in drug discovery, clinical research, regenerative medicine, personalized medicine, and disease research are strengthening market growth. The integration of automation, advanced data analytics, and digital technologies is also transforming conventional facilities into virtual biobanks.

Biobanking Market Trends

Sustainable Biobanking and Virtual Biobanking: Sustainability is becoming an important priority for biobank operators because long-term financial and operational stability is essential for maintaining sample repositories. At the same time, virtual biobanking technologies are improving sample visibility, data management, accessibility, and operational efficiency. Advanced software platforms are helping organizations streamline sample tracking and distribution while improving service quality.

Market Drivers

Growing Demand for Cord Blood and Stem Cell Storage: Cord blood is an important source of stem cells used in clinical research and regenerative medicine. Increasing interest in stem cell preservation and the establishment of specialized stem cell biobanks are supporting market opportunities.

Expansion of Virtual Biobanking Software: Digital platforms are enabling researchers and pharmaceutical companies to access sample information more efficiently. The adoption of software-based biobanking systems is expected to improve operational efficiency and generate additional market opportunities.

Increasing Disease Research: The rising prevalence of cancer, Alzheimer's disease, respiratory disorders, and other chronic conditions is increasing demand for high-quality biological samples for research and therapeutic development.

Market Restraints

Ethical and Regulatory Challenges: Informed consent, privacy, sample handling, storage, and distribution create significant ethical requirements. Emerging countries may face additional challenges because of lower literacy levels, limited training, insufficient counseling, and misconceptions surrounding biobanking. These factors can restrict market expansion.

Biobanking Market Segmentation Analysis

By Sample Storage: The market is segmented into blood, cells & tissue, and others. The blood segment dominated the market in terms of market value and market share, supported by extensive demand from pharmaceutical companies and academic institutions. Cells and tissues are expected to experience strong growth because of increasing research into cancer, Alzheimer's disease, regenerative medicine, and other complex disorders.

By Application: The market includes regenerative medicines, life science, and others. The life science segment dominated the market, supported by increasing sample requirements from academic institutions and pharmaceutical R&D organizations. Regenerative medicine is expected to record strong growth due to increasing clinical studies and personalized medicine research.

By Settings: The market is divided into academic medical institutions and pharmaceutical & biotechnology companies. Academic medical institutions have held a leading position because of increasing R&D investments and growing demand for samples for biomedical research.

Regional Analysis

Europe: Europe dominated the global market with a 35.59% share in 2025, supported by established biobanks and a strong biomedical research ecosystem.

North America: North America holds the second position, driven by clinical trials, pharmaceutical research, and increasing adoption of virtual biobank technologies.

Asia Pacific: Asia Pacific is expected to register higher growth during the forecast period due to increasing investments in biobank infrastructure and rising demand for blood and cell samples.

Latin America and Middle East & Africa: These regions are expected to witness comparatively slower growth because of ethical challenges, limited infrastructure, and lower investments in biobank maintenance.

Key Industry Players

Prominent organizations and companies profiled in the Biobanking Market Report include Medizinische Universitat Graz, UK Biobank, Shanghai Zhangjiang Biobank, Isenet Biobanking, Hamilton Company, Thermo Fisher Scientific Inc., ProMedDx, IBBL, Brooks Life Sciences, and ASKION.

Key Industry Developments

U.K. Biobank expanded its database with metabolomics biomarker data from a study involving approximately 120,000 participants. Precision for Medicine announced the acquisition of ProMedDx and GLAS to strengthen its biospecimen capabilities. IBBL also reported positive results from its Proficiency Testing programme in China, supporting greater standardization of biobanking and laboratory practices.

Future Outlook

The Biobanking Market Forecast remains positive as pharmaceutical R&D, clinical trials, regenerative medicine, personalized healthcare, and advanced sample-management technologies continue to expand. Automation, virtual biobanking, sustainable operating models, and increasing investments in emerging markets are expected to create significant Market Opportunities through 2034.

Conclusion

The global Biobanking Market is positioned for substantial long-term expansion, increasing from USD 83.29 billion in 2025 to USD 91.05 billion in 2026 and reaching USD 185.59 billion by 2034. Rising demand for biological samples, growing disease research, stem cell preservation, regenerative medicine, and digital biobanking technologies will remain important growth factors. Despite ethical, regulatory, and sustainability challenges, continued investment in biobank infrastructure and advanced technologies is expected to strengthen the market's overall Market Outlook, Market Growth, and Market Opportunities through 2034.

Unit Value (USD billion)

Segmentation By Sample Storage

• Blood
• Cells & Tissues
• Others

By Application

• Regenerative Medicines
• Life Science
• Others

By Settings

• Academic Medical Institutions
• Pharmaceutical & Biotechnological Companies

By Geography

• North America (U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
• Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
• Latin America (Brazil, Mexico, and Rest of Latin America)
• Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

Table of Content

1. Introduction

• 1.1. Others Scope
• 1.2. Market Segmentation
• 1.3. Others Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Overview: Trends in Biobanking Market
• 4.2. Prevalence of Key Diseases - By Key Countries
• 4.3. Overview: Number of Biobanks - By Key Countries
• 4.4. Key Industry Developments - Mergers, Acquisitions, and Partnerships

5. Global Biobanking Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Analysis, Insights and Forecast - By Sample Storage
  • 5.2.1. Blood
  • 5.2.2. Cells & Tissues
  • 5.2.3. Others
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Regenerative Medicines
  • 5.3.2. Life Science
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By Settings
  • 5.4.1. Academic Medical Institutions
  • 5.4.2. Pharmaceutical & Biotechnology Companies
• 5.5. Market Analysis, Insights and Forecast - By Geography
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Biobanking Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Analysis, Insights and Forecast - By Sample Storage
  • 6.2.1. Blood
  • 6.2.2. Cells & Tissues
  • 6.2.3. Others
• 6.3. Market Analysis, Insights and Forecast - By Application
  • 6.3.1. Regenerative Medicines
  • 6.3.2. Life Science
  • 6.3.3. Others
• 6.4. Market Analysis, Insights and Forecast - By Settings
  • 6.4.1. Academic Medical Institutions
  • 6.4.2. Pharmaceutical & Biotechnology Companies
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Biobanking Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Analysis, Insights and Forecast - By Sample Storage
  • 7.2.1. Blood
  • 7.2.2. Cells & Tissues
  • 7.2.3. Others
• 7.3. Market Analysis, Insights and Forecast - By Application
  • 7.3.1. Regenerative Medicines
  • 7.3.2. Life Science
  • 7.3.3. Others
• 7.4. Market Analysis, Insights and Forecast - By Settings
  • 7.4.1. Academic Medical Institutions
  • 7.4.2. Pharmaceutical & Biotechnology Companies
• 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.5.1. U.K.
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Spain
  • 7.5.5. Italy
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia Pacific Biobanking Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Analysis, Insights and Forecast - By Sample Storage
  • 8.2.1. Blood
  • 8.2.2. Cells & Tissues
  • 8.2.3. Others
• 8.3. Market Analysis, Insights and Forecast - By Application
  • 8.3.1. Regenerative Medicines
  • 8.3.2. Life Science
  • 8.3.3. Others
• 8.4. Market Analysis, Insights and Forecast - By Settings
  • 8.4.1. Academic Medical Institutions
  • 8.4.2. Pharmaceutical & Biotechnology Companies
• 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.5.1. Japan
  • 8.5.2. China
  • 8.5.3. India
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Biobanking Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Analysis, Insights and Forecast - By Sample Storage
  • 9.2.1. Blood
  • 9.2.2. Cells & Tissues
  • 9.2.3. Others
• 9.3. Market Analysis, Insights and Forecast - By Application
  • 9.3.1. Regenerative Medicines
  • 9.3.2. Life Science
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By Settings
  • 9.4.1. Academic Medical Institutions
  • 9.4.2. Pharmaceutical & Biotechnology Companies
• 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Biobanking Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. Market Analysis, Insights and Forecast - By Sample Storage
  • 10.2.1. Blood
  • 10.2.2. Cells & Tissues
  • 10.2.3. Others
• 10.3. Market Analysis, Insights and Forecast - By Application
  • 10.3.1. Regenerative Medicines
  • 10.3.2. Life Science
  • 10.3.3. Others
• 10.4. Market Analysis, Insights and Forecast - By Settings
  • 10.4.1. Academic Medical Institutions
  • 10.4.2. Pharmaceutical & Biotechnology Companies
• 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.5.1. GCC Countries
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Key Industry Developments
• 11.2. Global Market Share Analysis (2025)
• 11.3. Competition Dashboard
• 11.4. Comparative Analysis - Major Players
• 11.5. Company Profiles
  • 11.5.1. Hamilton Company
    • 11.5.1.1. Overview,
    • 11.5.1.2. Sample Storages & Services,
    • 11.5.1.3. SWOT Analysis,
    • 11.5.1.4. Recent Developments,
    • 11.5.1.5. Strategies,
    • 11.5.1.6. Financials (Based on Availability)
  • 11.5.2. Thermo Fisher Scientific Inc.
    • 11.5.2.1. Overview,
    • 11.5.2.2. Sample Storages & Services,
    • 11.5.2.3. SWOT Analysis,
    • 11.5.2.4. Recent Developments,
    • 11.5.2.5. Strategies,
    • 11.5.2.6. Financials (Based on Availability)
  • 11.5.3. Brooks Life Sciences
    • 11.5.3.1. Overview,
    • 11.5.3.2. Sample Storages & Services,
    • 11.5.3.3. SWOT Analysis,
    • 11.5.3.4. Recent Developments,
    • 11.5.3.5. Strategies,
    • 11.5.3.6. Financials (Based on Availability)
  • 11.5.4. Medizinische Universitat Graz
    • 11.5.4.1. Overview,
    • 11.5.4.2. Sample Storages & Services,
    • 11.5.4.3. SWOT Analysis,
    • 11.5.4.4. Recent Developments,
    • 11.5.4.5. Strategies,
    • 11.5.4.6. Financials (Based on Availability)
  • 11.5.5. Isenet Biobanking
    • 11.5.5.1. Overview,
    • 11.5.5.2. Sample Storages & Services,
    • 11.5.5.3. SWOT Analysis,
    • 11.5.5.4. Recent Developments,
    • 11.5.5.5. Strategies,
    • 11.5.5.6. Financials (Based on Availability)
  • 11.5.6. ProMedDx
    • 11.5.6.1. Overview,
    • 11.5.6.2. Sample Storages & Services,
    • 11.5.6.3. SWOT Analysis,
    • 11.5.6.4. Recent Developments,
    • 11.5.6.5. Strategies,
    • 11.5.6.6. Financials (Based on Availability)
  • 11.5.7. IBBL
    • 11.5.7.1. Overview,
    • 11.5.7.2. Sample Storages & Services,
    • 11.5.7.3. SWOT Analysis,
    • 11.5.7.4. Recent Developments,
    • 11.5.7.5. Strategies,
    • 11.5.7.6. Financials (Based on Availability)
  • 11.5.8. ASKION
    • 11.5.8.1. Overview,
    • 11.5.8.2. Sample Storages & Services,
    • 11.5.8.3. SWOT Analysis,
    • 11.5.8.4. Recent Developments,
    • 11.5.8.5. Strategies,
    • 11.5.8.6. Financials (Based on Availability)
  • 11.5.9. UK Biobank
    • 11.5.9.1. Overview,
    • 11.5.9.2. Sample Storages & Services,
    • 11.5.9.3. SWOT Analysis,
    • 11.5.9.4. Recent Developments,
    • 11.5.9.5. Strategies,
    • 11.5.9.6. Financials (Based on Availability)
  • 11.5.10. Shanghai Zhangjiang Biobank
    • 11.5.10.1. Overview,
    • 11.5.10.2. Sample Storages & Services,
    • 11.5.10.3. SWOT Analysis,
    • 11.5.10.4. Recent Developments,
    • 11.5.10.5. Strategies,
    • 11.5.10.6. Financials (Based on Availability)
  • 11.5.11. Other Prominent Players
    • 11.5.11.1. Overview,
    • 11.5.11.2. Sample Storages & Services,
    • 11.5.11.3. SWOT Analysis,
    • 11.5.11.4. Recent Developments,
    • 11.5.11.5. Strategies,
    • 11.5.11.6. Financials (Based on Availability)

12. Strategic Recommendations